Information & Referral

If you have come to our site seeking information, guidance, or referral services for yourself or another person, you have come to the right place. Wellspring is here to provide education and support to those who need assistance confronting the disease of alcoholism and drug dependence.

Information & Referral

Treatment Referrals
Suffering from an addiction problem? We can help you find a treatment facility. You can either browse through our local Treatment Directory, allow us to make suggested referrals by using our self-administered Screening Tool, or if you prefer speaking with one of our professionals, call our confidential Referral Helpline. We are available Monday through Friday from 8 a.m. to 9 p.m. You can also contact us via email at While not intended to diagnose a substance abuse problem, each of these options will help narrow your search for a program that best meets your needs. Note that the options provided do not represent an exhaustive list of all available programs or constitute an endorsement of particular programs. However, these are programs we have worked with and have consistently received positive feedback from those who have accessed their services. If you live outside of Middlesex County New Jersey, you can get help now by calling the New Jersey Addiction Services Hotline anytime at 844-276-2777. You can also access the New Jersey Mental Health Cares Information and Referral Helpline at 1-866-202-HELP (4357).
If you live outside of New Jersey, reach out to the National Council on Alcoholism and Drug Dependence at or 212-269-7797 to find your nearest local resources.
Jason Surks Memorial Resource Center
The Jason Surks Memorial Prevention Resource Center at Wellspring serves as a clearinghouse for free information about alcohol, tobacco and other drugs. Explore our vast collection of online information and helpful links, or visit us at our East Brunswick, NJ location to access free pamphlets, posters and DVD lending library.
More than just a physical and web-based library, our Resource Center is people. If you need assistance planning an educational program, need information for a health fair, or would like to contract with our staff to provide presentations in your community, please call us at 732-254-3344 or send us an email request at

FDA Issues Guidelines for Drug Industry on Developing Abuse-Deterrent Opioids

image The Food and Drug Administration (FDA) recently issued guidelines for drug manufacturers on developing opioid painkillers that are more difficult to abuse.

The guidelines recommend the types of studies needed to prove drugs can deter abuse, The Wall Street Journal reports.

The FDA guidelines also make recommendations about how these studies should be performed and evaluated. They discuss what labeling claims may be approved based on the results of those studies, according to an agency news release.

The FDA said it hopes to encourage drug makers to develop opioids that are more difficult to crush, inject or snort to produce a more intense high. The agency noted even abuse-deterrent formulations are not "abuse-proof."

"We hope that this guidance is going to provide an incentive for real abuse-deterrent products," said Dr. Douglas Throckmorton, Deputy Director of Regulatory Programs at the FDA's Center for Drug Evaluation. "We hope the industry will find that this guidance lays out a road map" for how to develop abuse-deterrent painkillers that will gain FDA approvals, he told the newspaper.

About 30 drug makers have been in recent discussions with the FDA about making abuse-deterrent formulations, the agency said.

Dr. Andrew Kolodny, President of Physicians for Responsible Opioid Prescribing, recommended other steps the FDA could take to reduce opioid abuse. These include taking larger dosages off the market, and prohibiting marketing of powerful opioids for certain conditions, such as low back pain.